GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Recordati SpA (LTS:0KBS) » Definitions » Debt-to-Revenue

Recordati SpA (LTS:0KBS) Debt-to-Revenue : 0.70 (As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Recordati SpA Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Recordati SpA's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was €293 Mil. Recordati SpA's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was €1,265 Mil. Recordati SpA's annualized Revenue for the quarter that ended in Sep. 2024 was €2,230 Mil. Recordati SpA's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 was 0.70.


Recordati SpA Debt-to-Revenue Historical Data

The historical data trend for Recordati SpA's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Recordati SpA Debt-to-Revenue Chart

Recordati SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.74 0.73 0.63 0.93 0.87

Recordati SpA Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.89 0.86 0.71 0.73 0.70

Competitive Comparison of Recordati SpA's Debt-to-Revenue

For the Drug Manufacturers - General subindustry, Recordati SpA's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Recordati SpA's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Recordati SpA's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Recordati SpA's Debt-to-Revenue falls into.



Recordati SpA Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Recordati SpA's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(455.684 + 1353.216) / 2082.331
=0.87

Recordati SpA's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(292.767 + 1264.884) / 2229.656
=0.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2024) Revenue data.


Recordati SpA Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Recordati SpA's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Recordati SpA Business Description

Address
Via Matteo Civitali 1, MIlan, ITA, 20148
Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment which includes the production of active ingredients.

Recordati SpA Headlines

No Headlines